It was demonstrated that the hypoxia- and IL6-mediated activation of autophagy promotes MCL cell survival and chemoresistance, and that the inhibition of autophagy overcomes the resistance to mTOR inhibitors [112,113,114]. This evidence concerns the gene MTOR and mantle cell lymphoma.